Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 9:8:23.
doi: 10.1186/s13601-018-0212-0. eCollection 2018.

Severity of allergic rhinitis impacts sleep and anxiety: results from a large Spanish cohort

Affiliations

Severity of allergic rhinitis impacts sleep and anxiety: results from a large Spanish cohort

R Muñoz-Cano et al. Clin Transl Allergy. .

Abstract

Background: Allergic rhinitis (AR) is a highly prevalent disease that generates high social and health care costs and also has a significant effect on quality of life and quality of sleep. It has also been related to some psychological disorders like anxiety or depression.

Objective: To evaluate anxiety, depression, and quality of sleep and life alteration in a group of patients with perennial AR compared to a group of seasonal AR patients.

Methods: Six-hundred seventy adults (> 18 years) with perennial and seasonal AR were recruited consecutively in 47 centers in Spain. Individuals were grouped in "Perennial" and "Seasonal" according to the seasonality of their symptoms. Anxiety, depression, sleep quality and health related quality of life were evaluated using the Hospital Anxiety and Depression Scale, Medical Outcomes Study Sleep Scale (MOS Sleep Scale) and the Health-related quality of life questionnaire ESPRINT-15, respectively. Both groups of patients were evaluated in and out of the pollen season.

Results: AR symptoms are related to worse quality of life and more anxiety and depression symptoms. Indeed, symptom severity also correlates with worse outcomes (quality of life, sleep and depression/anxiety) regardless allergen seasonality. Symptoms severity, compared with seasonality and persistence, is the most important factor related with more anxiety and depression and poor sleep. However, symptoms severity, persistence and seasonality are independently affecting the quality of life in patients with AR.

Conclusions: Although AR symptoms have a great impact on depression and anxiety symptoms, quality of life and quality of sleep in all AR patients, as expected, individuals with more severe AR seem to suffer more intensely their effects.

Keywords: Allergic rhinitis; Anxiety; Depression; Sleep.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Study flow chart. HAD: Hospital Anxiety and Depression Scale; MOS: Medial Outcomes Study Sleep Scale; ESPRINT-15: health-related quality of life in adults with allergic rhinitis
Fig. 2
Fig. 2
a Impact of allergen exposure on anxiety and depression measured by HAD scale in patients with perennial symptoms compared with seasonal allergic rhinitis patients out of pollen season. b Impact of allergen exposure on quality of life measured by ESPRINT-15 in patients with perennial symptoms compared with seasonal allergic rhinitis patients out of pollen season. OPS: out of pollen season. HAD: Hospital Anxiety and Depression Scale. ESPRINT-15: Health-related quality of life questionnaire. *p < 0.05
Fig. 3
Fig. 3
a Impact of allergen exposure on anxiety and depression measured by HAD scale in allergic rhinitis patients with seasonal symptoms in and out of pollen season. b Impact of allergen exposure on quality of sleep measured by MOS scale in allergic rhinitis patients with seasonal symptoms in and out of pollen season. c Impact of allergen exposure on quality of life measured by ESPRINT-15 in allergic rhinitis patients with seasonal symptoms in and out of pollen season. ESPRINT-15: Health-related quality of life questionnaire. HAD: Hospital Anxiety and Depression Scale. MOS: Medical Outcomes Study Sleep Scale. *p < 0.05

Similar articles

Cited by

References

    1. Colás C, Brosa M, Antón E, Montoro J, Navarro A, Dordal MT, et al. Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN study. Allergy. 2017;6:959–966. doi: 10.1111/all.13099. - DOI - PubMed
    1. Colás C, Galera H, Añibarro B, Soler R, Navarro A, Jáuregui I, et al. Disease severity impairs sleep quality in allergic rhinitis (the SOMNIAAR study) Clin Exp Allergy. 2012;42:1080–1087. doi: 10.1111/j.1365-2222.2011.03935.x. - DOI - PubMed
    1. Valero A, Muñoz-Cano R, Sastre J, Navarro AM, Martí-Guadaño E, Dávila I, et al. The impact of allergic rhinitis on symptoms, and quality of life using the new criterion of ARIA severity classification. Rhinology. 2012;50:33–36. - PubMed
    1. Valero A, Izquierdo I, Sastre J, Navarro AM, Baró E, Martí-Guadaño E, et al. ESPRINT-15 questionnaire (Spanish version): reference values according to disease severity using both the original and the modified ARIA classifications. J Investig Allergol Clin Immunol. 2013;23:14–19. - PubMed
    1. Gamboa PM. The epidemiology of drug allergy-related consultations in Spanish Allergology services: Alergológica-2005. J Investig Allergol Clin Immunol. 2009;19(Suppl 2):45–50. - PubMed